Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry.
Chimenti MS, Fatica M, Fornaro M, Lopalco G, Corrado A, Rotondo C, Semeraro A, Colella S, Praino E, Gorla R, Bazzani C, Babaglioni G, Foti R, Floris A, Frediani B, Atzeni F, Conti F, Cauli A, Caporali R, Iannone F, Guiducci S. Chimenti MS, et al. Among authors: fornaro m. Clin Exp Rheumatol. 2024 Nov;42(11):2221-2228. doi: 10.55563/clinexprheumatol/udiit0. Epub 2024 Jul 24. Clin Exp Rheumatol. 2024. PMID: 39051160 Free article.
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
Iannone F, Salaffi F, Fornaro M, Di Carlo M, Gentileschi S, Cantarini L, Lopalco G. Iannone F, et al. Among authors: fornaro m. Eur J Clin Invest. 2018 Nov;48(11):e13013. doi: 10.1111/eci.13013. Epub 2018 Aug 23. Eur J Clin Invest. 2018. PMID: 30079593
Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).
Carlino G, Fornaro M, Santo L, Bucci R, Semeraro A, Quarta L, D'Onofrio F, Marsico A, Zuccaro C, Falappone PC, Mazzotta D, Cantatore FP, Muratore M, Iannone F. Carlino G, et al. Among authors: fornaro m. Reumatismo. 2019 Apr 1;71(1):24-30. doi: 10.4081/reumatismo.2019.1154. Reumatismo. 2019. PMID: 30932440 Free article.
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F. Bettiol A, et al. Among authors: fornaro m. Int J Mol Sci. 2019 Apr 17;20(8):1898. doi: 10.3390/ijms20081898. Int J Mol Sci. 2019. PMID: 30999610 Free PMC article. Review.
Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al.
Fornaro M, Cacciapaglia F, Venerito V, Lopalco G, Iannone F. Fornaro M, et al. Ann Rheum Dis. 2020 Sep;79(9):e106. doi: 10.1136/annrheumdis-2019-216407. Epub 2019 Oct 11. Ann Rheum Dis. 2020. PMID: 31604705 No abstract available.
470 results